The high levels of IL‐6, TNF‐α, and IFN‐γ caused by hepatic PANX1 deficiency in endotoxemia were significantly decreased by rIL‐33 treatment (Figure 8J‐L). This evidence concerns the gene PANX1 and serum lipopolysaccharide activity.